 Although bariatric surgery is a proven means of weight<symptom> loss<symptom> and treatment of obesity-related comorbidities in morbidly obese patients , it is not yet clear how it affects outcomes after total joint arthroplasty in this high-risk patient population. This article explores the effects of obesity and bariatric surgery on osteoarthritis and total joint arthroplasty , and also discusses the financial and ethical implications of use of bariatric surgery for risk reduction before total joint arthroplasty.